Percutaneous Large Hole Vascular Closure
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Vivasure MedicalIreland - Galway
3 programsPPCIN/A1 trial
PerQseal Plus DeviceN/A1 trial
PerQseal® Closure Device SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Vivasure MedicalPerQseal® Closure Device System
Vivasure MedicalPerQseal Plus Device
Vivasure MedicalPPCI
Clinical Trials (3)
Total enrollment: 183 patients across 3 trials
PerQseal® Clinical Study
Start: Mar 2023Est. completion: Jun 2025149 patients
N/AActive Not Recruiting
PerQseal®+ Early Feasibility Study
Start: Mar 2022Est. completion: Jul 202215 patients
N/ACompleted
PerQseal® Impella Early Feasibility Study
Start: Jun 2021Est. completion: Mar 202319 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.